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Substantia nigra pars reticulata (SNr), the major output nucleus of the basal ganglia,
receives dopamine from dendrites extending from dopaminergic neurons of the adjacent
nucleus pars compacta (SNc), which is known for its selective degeneration in
Parkinson’s disease. As a recipient for dendritically released dopamine, the dopamine
D1 receptor (D1R) is a primary candidate due to its very dense immunoreactivity
in the SNr. However, the precise location of D1R remains unclear at the cellular
level in the SNr except for that reported on axons/axon terminals of presumably
striatal GABAergic neurons. To address this, we used D1R promotor-controlled,
mVenus-expressing transgenic mice. When cells were acutely dissociated from SNr of
mouse brain, prominent mVenus fluorescence was detected in fine processes of glia-like
cells, but no such fluorescence was detected from neurons in the same preparation,
except for the synaptic bouton-like structure on the neurons. Double immunolabeling
of SNr cells dissociated from adult wild-type mice brain further revealed marked
D1R immunoreactivity in the processes of glial fibrillary acidic protein (GFAP)-positive
astrocytes. Such D1R imunoreactivity was significantly stronger in the SNr astrocytes
than that in those of the visual cortex in the same preparation. Interestingly, GFAP-positive
astrocytes dissociated from the striatum demonstrated D1R immunoreactivity, either
remarkable or minimal, similarly to that shown in neurons in this nucleus. In contrast,
in the SNr and visual cortex, only weak D1R immunoreactivity was detected in the
neurons tested. These results suggest that the SNr astrocyte may be a candidate
recipient for dendritically released dopamine. Further study is required to fully elucidate
the physiological roles of divergent dopamine receptor immunoreactivity profiles in
GFAP-positive astrocytes.
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INTRODUCTION
The midbrain nucleus substantia nigra pars reticulata (SNr)
consists mostly of gamma-aminobutyric acid-ergic (GABAergic)
neurons. GABAergic SNr neurons receive inhibitory and
excitatory axonal inputs from striatum and subthalamus,
respectively, and send in turn their axons to remote nuclei, such
as superior colliculus, thalamus, and brain stem (Fallon and
Loughlin, 1995).
It is well accepted that dopaminergic neurons located in
the adjacent nucleus substantia nigra pars compacta (SNc)
release dopamine (DA) from their dendrites (dendritic release)
extending deeply into SNr (Geffen et al., 1976; Korf et al.,
1976; Nieoullon et al., 1977; Reubi et al., 1977; Cheramy et al.,
1981; Falkenburger et al., 2001). Whereas, the significance of
dopamine released from nigrostriatal axons has been extensively
studied both physiologically and pathophysiologically, much less
attention has been paid to dopamine dendritically released in
the SNr, in particular to the cellular entity expressing dopamine
receptors (Dunnett and Bjorklund, 1999; Schultz, 2015; Volkow
and Morales, 2015).
Of five dopamine receptor subtypes, it has been reported that
dopamine D1 receptor (D1R) is strongly expressed in the SNr,
whereas expression of dopamine D2 receptor (D2R) is relatively
sparse in this nucleus (Levey et al., 1993; Fallon and Loughlin,
1995).
Regarding the precise localization of D1R in the SNr, several
groups have provided evidence for its expression on axons
and axon terminals of GABAergic neurons that may have
originated in the striatum (Levey et al., 1993; Fallon and
Loughlin, 1995; Yung et al., 1995; Caille et al., 1996; Miyazaki and
Lacey, 1998; Kliem et al., 2010). However, the very dense D1R
immunoreactivity in SNr (Levey et al., 1993; Caille et al., 1996)
led us to explore further whether other cellular entities might also
contribute to the expression.
Over 30 years ago, Reubi and Sandri reported in
electronmicroscopic/freeze etching studies that nigral dendrites
fail to form dendro-dendritic contacts in the SNr, but are
consistently separated by one or two thin glial sheaths (Reubi
and Sandri, 1979). Interestingly, Bosson et al. reported that acute
interruption of dopaminergic transmission increased astrocyte
synchrony in the SNr (Bosson et al., 2015).
Thus, as the major glial cell, the astrocyte might well express
D1R on its thin processes in the SNr. To address this, we initially
conducted double immunolabeling of SNr slices with antibodies
for D1R and 3-PGDH (3-phosphoglycerate dehydrogenase;
Yamasaki et al., 2001), a marker that can stain fine processes
of astrocytes that was used here instead of an antibody against
intermediate filament glial fibrillary acidic protein (GFAP).
However, identification of the D1R-positive cellular entity using
confocal microscopy was difficult due to its extremely fine and
dense pattern in the SNr, although considerable overlapping of
the immunoreactivity for D1R and 3-PGDH was apparent.
We therefore examined acutely dissociated cells from D1R
promoter-controlled, mVenus (a variant of enhanced yellow
fluorescent protein)-expressing transgenic (Drd1-mVenus) mice
brain (Nagai et al., 2016). For further identification of
mVenus-positive cells, double immunolabeling with antibodies
against D1R and GFAP was conducted in the SNr of adult wild-
type mice brains. For comparison, cells dissociated from the
visual cortex and the striatum also were analyzed.
Our results suggest involvement of astrocytes in D1R
immunoreactivity in the SNr and heterogeneity of astrocytes in
adult mouse brain.
MATERIALS AND METHODS
Animals
Animals used in the present study were male C57BL/6J mice,
mice lacking D1R (D1R-KO mice; RBRC01080; Tran et al., 2008;
Nakamura et al., 2014), and Drd1-mVenus mice (RBRC03111).
Drd1-mVenus mice were developed by one of the authors of
the present study (KK, see Nagai et al., 2016 for detail). The
D1R-KO mice and Drd1-mVenus mice used were obtained from
RIKEN BioResource Center (Tsukuba, Japan). Their genotypes
were determined by PCR analysis of genomic DNA extracted
from the tail of each mouse.
Both the D1R-KO mice and Drd1-mVenus mice were
generated on a C57BL/6J background. D1R-KO mice were
obtained by crossing heterozygous D1R-KO mice. Homozygous
Drd1-mVenus transgenic mice were obtained by crossing
heterozygous Drd1-mVenus transgenic mice. Determination
of homozygosity of Drd1-mVenus mice was made based on
the genotype of 8 consecutive pups produced by crossing
presumptive homozygous male (or female) mice with female (or
male) C57BL/6J mice. These transgenic mice expressed mVenus
in a D1R-promotor-dependent manner.
All animal experiments were carried out in accordance with
a protocol approved by the Animal Care and Use Committee of
Hirosaki University Graduate School of Medicine.
Brain Slice Preparation for
Immunohistochemistry
Four adult D1R-KO and ten wild-type mice (39–47 days old)
were deeply anesthetized with urethane (1.6 g/kg) and perfused
through the heart with 4% paraformaldehyde in 0.1 M phosphate
buffer (pH 7.4) following 0.1 M phosphate buffer (pH 7.4)
containing heparin (10,000 units/l, Mochida Pharmaceutical,
Tokyo, Japan) at room temperature. After post-fixation at 4◦C,
the brains were dissected out, and coronal or sagittal sections
were then cut with cryostat at 50 µm in thickness and were
processed for immunohistochemistry using the avidin-biotin-
peroxidase complex method. Briefly, the sections were treated
with Phosphate buffered saline (PBS) containing 0.5% Triton X-
100 for 12 h at 4◦C, with 0.3% H2O2 in PBS for 1 h at room
temperature, and with 1% normal donkey serum in PBS for 1
h at room temperature. Washing previous solutions with PBS
was done between each treatment. The sections then were treated
with a primary antibody for 48 h at 4◦C, with a biotinylated
secondary antibody for 1 h at room temperature and then with
an avidin-biotin peroxidase complex (2.5 µl/ml, Elite ABC kit,
Vector, Burlingame, CA, USA) for 1 h at room temperature, with
washing between each treatment. After washing, sections were
visualized with 0.05MTris-HCl buffer (pH 7.4) containing 0.02%
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3-3′-diaminobenzidine tetrahydrochloride (DAB) and 0.006%
H2O2 for 15–30 min at room temperature. The sections were
mounted on glass slides, embedded, and examined with a light
microscope (BX-50, Olympus, Tokyo, Japan).
Preparation from Drd1-mVenus Mice
Five Drd1-mVenus male mice (47–72 days old) were
deeply anesthetized by urethane (1.6 g/kg) and sacrificed
by decapitation. The brain was quickly isolated from the skull,
and a 500 µm-thick coronal slice containing both SNr (a
section at the oculomotor nerve) and visual cortex was then
dissected out. Slices were recovered for 1 h in a Krebs-Ringer
solution containing 124 mM NaCl, 26 mM NaHCO3, 4 mM
KCl, 1.24 mM KH2PO4, 1.3 mM MgSO4·7H2O, 1 mM CaCl2,
10 mM glucose, saturated with 95% O2/5% CO2 (pH 7.4) at
room temperature. Two Drd1-mVenus mice were used for
examining the mVenus signal throughout the brain in coronal
sections. Fluorescence images were captured by a CCD camera
(Retiga 2000R, QImaging, Surrey, British Columbia, Canada)
and mounted on an inverted microscope (Eclipse Ti-E, Nikon,
Tokyo) with a standard FITC filter set.
The remaining Drd1-mVenus mice were used for cell
dissociation. In HEPES buffer solution (150 mM NaCl, 5 mM
KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM HEPES, 10 mM
glucose; pH was adjusted at 7.33–7.35 by tris hydroxymethyl
aminomethan), single neurons and glia-like cells were dissociated
from a small piece of SNr tissue by slightly modifying our
previous method (Yamada et al., 2001) so that the thin processes
of the glia-like cells were preserved as far as possible. SNr and
SNc were identified in reference to Paxinos, G. and Franklin,
K.B.J. “The mouse brain in stereotaxic coordinates” (Paxinos and
Franklin, 2001).
Briefly, the dorsolateral region of SNr tissue (Figure 1) was
carefully punched out by a customized needle (the major and
the minor outer diameter were 1.6 and 1.0 mm, respectively, wall
thickness was 200 µm) from a 500 µm-thick coronal slice cut
using a microslicer (Linear Slicer Pro7, Dosaka, Tokyo) within
the range of 0–0.7 mm anterior to the interaural line, and was
subjected to mild digestion by pronase (Calbiochem 537088,
16.7mg in 100 mL of Krebs-Ringer solution, for 110 min at
31◦C). Then cells then were gently dissociated from the tissue
and plated on cover glasses (MATSUNAMI; No. 0, 13 × 22 mm)
coated with poly-L-lysine (1:500 dilution of 150 mM borate stock
solution).
Antibodies
Primary antibodies used were polyclonal rabbit anti-GFAP
antibody (Z0334; 1:2500, DAKO, Carpinteria, CA, USA),
monoclonal anti-tyrosine hydroxylase (TH) antibody (MAB318;
1:2000, Millipore, Billerica, MA, USA), rabbit anti-parvalbumin
antibody (PV-28; 1:2000, Swant, Marly, Switzerland), goat
polyclonal anti-mouse D1R antibody (D1R-Go-Af1000; 1:200,
Frontier Institute, Sapporo, Japan; Narushima et al., 2006),
and guinea pig anti-mouse D2R antibody (1:1000). The anti-
D2R antibody was kindly provided by Prof. Ryuichi Shigemoto
(National Institute for Physiological Sciences at that time).
Secondary antibodies used for the avidin-biotin-peroxidase
complex method were biotinylated donkey anti-rabbit antibody
(711-065-152; 1:1000, Jackson ImmunoResearch Laboratories,
West Grove, PA, USA) for parvalbumin, donkey anti-mouse
antibody (715-065-151; 1:1000, Jackson ImmunoResearch
Laboratories) for TH, donkey anti-goat antibody (705-065-147;
1:1000, Jackson ImmunoResearch Laboratories) for D1R, and
biotinylated donkey anti-guinea pig antibody (706-065-148;
1:1000, Jackson ImmunoResearch Laboratories, West Grove, PA,
USA) for D2R.
Secondary antibodies used for immunocytochemistry of
acutely dissociated cells were Alexa Fluor 488 donkey anti-goat
IgG (A-11055; 1:1000, Life Technologies, Waltham, MA, USA)
and Cy3-conjugate and donkey anti-rabbit IgG (711-165-152;
1:400, Jackson ImmunoResearch Laboratories, West Grove, PA,
USA).
Immunocytochemistry of Cells Acutely
Dissociated from Brain of Wild-Type Mice
In a similar manner to the preparation from Drd1-mVenus
mice, cells were dissociated from SNr of the brain, but using
eight male adult C57BL/6J mice (wild-type, 52–78 days old).
For comparison, cells were dissociated from the visual cortex in
the same slice using an oval-shaped, customized biopsy needle
(the major and the minor outer diameter were 2.9 and 1.2 mm,
respectively, wall thickness was 200 µm) so that the gray matter
(layer II/III to VI) was included as far as possible.
For a further control, cells were also dissociated from the
caudate putamen (striatum). In detail, the brain was first cut
coronally into three pieces by dissection about 1.7–1.9 mm
anterior to the bregma and about 0–1.1 mm anterior to the
interaural line; the middle piece was placed on the stage of the
microslicer. A 500 µm-thick coronal slice was dissected out so
that it contained the striatum within the range of 1.1–0.3 mm
anterior to the bregma. As a result, the slice included the anterior
part of the striatum, just rostral to the coronal plane where the
anterior commissure crosses the midline. Two or three pieces of
punch-out were made by a customized needle (the major and the
minor outer diameter were 1.6 and 1.0 mm, respectively) from
the striatum in each hemisphere of two male adult wild type mice
(46 and 54 days old).
Acutely dissociated cells were fixed with 2% paraformaldehyde
in 0.1 M sodium phosphate buffer (pH 7.2–7.4) for 10 min at
room temperature, and washed 3 times with PBS for 5 min each.
Fixed cells were incubated with PBS containing 0.1% Triton X-
100 for 30 min at room temperature, and washed 3 times with
PBS for 5 min each. After blocking with PBS containing 10%
normal donkey serum (S30-100ML; Millipore, Temecula, CA,
USA) for 30 min at room temperature, cells were incubated
overnight with a mixture of primary antibodies diluted with PBS
containing 10% normal donkey serum at 4◦C. After washing
the primary antibodies 3 times with PBS for 10 min each,
they were incubated for 60 min with a mixture of secondary
antibodies at room temperature. After washing, nuclear staining
was performed with 4′,6-diamidino-2-phenylindole (DAPI) for
10 min at room temperature; cells were then mounted with
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FIGURE 1 | Immunoreactivity of anti-dopamine D1 and anti-dopamine D2 receptor antibodies used in wild-type mouse substantia nigra. (A) Dense
dopamine D1 receptor (D1R) immunoreactivity was detected in substantia nigra pars reticulata (SNr), but not in pars compacta (SNc). (B) Abundant GABAergic
neurons were shown in the SNr by parvalbumin (Parv) immunoreactivity. (C) Dopamine D2 receptor (D2R) immunoreactivity was remarkable in the SNc, but only
sparse in the SNr. (D) Tyrosine hydroxylase (TH) immunoreactivity was well correlated with D2R immunoreactivity in the substantia nigra. Dashed lines indicate the
outer boundary for dissecting out SNr tissue with a customized needle having 200 µm-thick wall. The orientation and scale are common to A–D.
PermaFluor (Thermo Scientific; Waltham, MA, USA). Cells
similarly processed but with no primary antibodies were used as
a control.
Confocal Microscopy
A laser confocal microscope (TCS-SP5, Leica Microsystems,
Mannheim, Germany) was used for imaging single cells. mVenus
images were obtained with an HCX PL APO CS 40x/1.25-0.75
OIL lens, then quantitatively compared in the same experimental
condition with the photomultiplier voltage at 480 V, scan
speed at 400 Hz, and pinhole size at 5 airy units. Images
were taken two times and averaged. Excitation and emission
wavelengths were 514 and 524–790 nm, respectively. For
D1R immunocytochemistry, Alexa Fluor 488 fluorescence was
captured and quantified similarly, but with the photomultiplier
voltage at 580 V. Excitation and emission wavelengths used
for detection of the Alexa Fluor 488 fluorescence were 488
and 498–538 nm, respectively. For GFAP immunocytochemistry,
Cy3 fluorescence was captured in the condition that GFAP
was most clearly detected. Excitation and emission wavelengths
for detection of the Cy3 fluorescence were 543 and 565–628
nm, respectively. For detecting DAPI fluorescence, excitation
and emission wavelengths at 405 and 415–600 nm were used,
respectively. Images were averaged three times.
An HC PL APO 20x/0.70 IMM lens was used for low-
magnification image acquisition in one case (Supplementary
Figure 4). The photomultiplier voltage for detecting Alexa Fluor
488 (D1R) and Cy3 (GFAP) was 680 and 640 V, respectively, in
this case.
For quantitative comparison of the fluorescence, a circular
region of interest (ROI, diameter = 5 µm) was placed over
the proximal processes of glia-like cells and in the cell body
for neurons. The mean fluorescence in the ROI was compared
among cells after subtraction of the background intensity using
the manufacturer’s software (LAS AF Lite, Leica Microsystems)
and Photoshop (Adobe Systems).
Statistics
Values are expressed as mean ± S.D. Statistical significance
was analyzed by unpaired t-test unless otherwise noted. For
D1R immunoreactivity of striatal cells, a cluster analysis was
conducted by Ward’s method (JMP ver.11.2, SAS Institute, Cary,
NC, USA).
RESULTS
Substantia nigra was identified in coronal slices of wild-type
mouse brains (Figure 1). Consistently with well established
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dopamine D1 and D2 receptor expressions in the midbrain
(Levey et al., 1993; Fallon and Loughlin, 1995; Caille et al., 1996),
the anti-D1R antibody used in the present study demonstrated
very dense immunoreactvity for D1R in SNr (Figure 1A;
Supplementary Figure 1B; see also Supplementary Figure 3A
for quantification), the region where abundant number of
parvalbumin-immunopositive cells were detected compared
to that in SNc (Figure 1B; Supplementary Figure 1A; see
also Supplementary Figure 2B for statistical comparison;
Supplementary Figure 3A), in a way somewhat more
robust in the dorsolateral part than in the ventromedial
part (Figures 1A,B; Supplementary Figures 2B,3A). The
intensity of immunoreactivity for D1R was highly correlated
with that for parvalbumin in the dorsolateral part of SNr
(Supplementary Figures 3A,C; pairwise Pearson correlation,
correlation coefficient = 0.808) as reported previously (Gerfen
et al., 1985; Rajakumar et al., 1994).
The specificity of the anti-D1R antibody used was further
confirmed in the brain of D1R-KO mice, which showed
no appreciable immunoreactivity for the anti-D1R antibody
(Supplementary Figure 1C). As reported in previous studies
(Fallon and Loughlin, 1995; Yung et al., 1995), our preparations
showed relatively sparse D2R immunoreactivity in SNr as
compared to that in SNc (Figure 1C; Supplementary Figures
3B,3D for quantification), which contained abundant TH-
immunopositive dopaminergic neurons dopaminergic neurons
(Figure 1D, Supplementary Figure 2A for statistical comparison,
p < 0.003, unpaired t-test). The intensity of immunoreactivity
for D2R was strongly correlated with that for TH in the
SN (Supplementary Figure 3B,D; pairwise Pearson correlation,
coefficient= 0.853).
To investigate the dense D1R immunoreactivity in SNr more
closely, we examined coronal brain slices of adult Drd1-mVenus
mice (Nagai et al., 2016). As shown, strong mVenus fluorescence
was highly localized in the SNr (Figures 2A–C, arrowheads). To
identify the cellular entity emitting mVenus fluorescence, the
SNr region was punched out from these slices, and the cells
were then carefully dissociated so that their fine processes were
preserved as far as possible, by modifying the method reported
previously (Yamada et al., 2001). As demonstrated in confocal
microscopic images, glia-like cells having small cell body (mean
longitudinal diameter of the cell body = 8.1 ± 1.4 µm, n = 167)
emitted prominent mVenus fluorescence, particularly in their
fine processes (Figures 2D–F, filled arrows). The fluorescence
intensity for the region of interest (ROI), which was set in the
proximal processes, was 353.8 ± 187.8 arbitrary units (a.u., n =
167) on average. In contrast, larger cells bearing dendrites (mean
longitudinal diameter = 17.3 ± 5.2 µm, n = 191), which were
presumably neurons as judged from our previous patch clamp
studies (Yamada et al., 2001), exhibited only weak fluorescence
(Figures 2D–F, empty arrows). When the ROI was placed in
the cell body of such neurons, the mean fluorescence intensity
(83.3 ± 54.0 a.u., n = 191) was significantly weaker than that in
the small glia-like cells (p < 0.0001, unpaired t-test), although
extremely small (<1 µm), synaptic bouton-like fluorescent dots
were found on the dendrites and/or the cell body in 142 of the
191 cells examined (see inset in Figure 2F). Another mVenus-
expressing cell shown in magnified view depicts a typical small
cell bearing “bushy” mVenus-positive processes (Figures 2G–I,
filled arrows). These results suggest D1R expression in the glia-
like cells in the SNr.
To investigate whether astrocytes are involved in the D1R-
expressing, glia-like cells in the SNr, we conducted double
immunofluorescence imaging of SNr cells dissociated from the
brains of eight adult wild-type mice with anti-D1R antibody in
combination with an antibody against GFAP, a specificmarker for
astrocytes. The results show remarkable D1R immunoreactivity
in most GFAP-positive astrocytes examined (Figures 3A–D; see
also Supplementary Figure 4). The mean longitudinal diameter
of the GFAP-positive cell bodies (8.0± 1.1 µm, n= 52) obtained
from the SNr was similar to that of the mVenus-expressing glia-
like cells in this nucleus. The mean fluorescence intensity of
D1R immunoreactivity in these GFAP-positive cells was 1662.5
± 691.9 a.u. (n = 52), when ROIs were positioned similarly to
those in mVenus-expressing cells.
In contrast, GFAP-negative, larger cells bearing a few thick
dendrites, presumably neurons (mean longitudinal diameter
= 19.0 ± 4.5 µm, n = 40), exhibited only weak D1R
immunoreactivity (Figures 3A–D, empty arrows), except for that
of the bouton-like fluorescent structures on the cell body and/or
dendrites in 23 of 40 cells (magnified view in Figure 3D inset).
Themean fluorescence intensity for D1R in the neurons obtained
from the SNr (541.7 ± 160.8 a.u. for a ROI positioned in the cell
body, n = 40) was much weaker than that of the GFAP-positive
astrocytes in the same nucleus (p < 0.0001, unpaired t-test; see
also Figure 6A).
For comparison, double immunocytochemistry was also
conducted for visual cortical cells dissociated from the same
coronal slices of the eight adult wild-type mice. As shown,
GFAP-positive astrocytes obtained from the visual cortex (mean
longitudinal diameter = 7.2 ± 1.0 µm, n = 39) showed
none or only weak D1R immunoreactivity when compared
in the same experimental condition as with the SNr cells
(Figures 4A–D, filled arrows). The mean fluorescence intensity
of D1R immunoreactivity in such GFAP-positive astrocytes
obtained from the visual cortex (374.4 ± 238.8 a.u., n = 39)
was significantly weaker than that of the GFAP-positive SNr
astrocytes (p< 0.0001, unpaired t-test; see also Figures 6A,B, red
triangles). Neurons dissociated from the visual cortex of the same
slices also showed a small D1R immunoreactivity (Figures 4A–D,
empty arrows; mean fluorescence intensity = 371.4 ± 171.9
a.u., n = 150), although the diameter of the neurons examined
was relatively small on average (12.9 ± 2.4 µm, n = 150; see
also Figure 6B) compared to that of SNr neurons (p < 0.0001,
unpaired t-test).
Interestingly, when we examined cells in the striatum
of a wild-type mouse in a similar manner, we noticed that
GFAP-positive astrocytes tended to express either abundant
D1R immunoreactivity (Figure 6C), as exemplified in
Figures 5A–D (filled arrowheads), or none or only a minimum
amount (Figure 6C), as shown in Figures 5E–H (empty
arrowheads).
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FIGURE 2 | Expression of mVenus signal in a coronal slice dissected from the Drd1-mVenus mouse brain and that in cells dissociated from the SNr of
the mouse. (A–C) Images of a 500 µm-thick coronal section, in which both SNr at the oculomotor nerve and visual cortex were included, revealing a prominent
mVenus signal in the SNr (arrowheads). (A), (B), and (C) show a bright field image, mVenus fluorescence, and a merged image, respectively. Note the considerable
difference in mVenus fluorescence between SNr and visual cortex. (D–F) Cells acutely dissociated from the SNr of adult Drd1-mVenus mouse. (D) Differential
interference contrast image. (E) A glia-like cell bearing mVenus-positive fine processes (filled arrow) and a neuron exhibiting a very weak mVenus fluorescence (empty
arrow). (F) Merged image of (D,E). Synaptic bouton-like structures showing mVenus signal (see inset for a magnified view). Nuclear staining with DAPI (blue) was
overlaid in (E,F). (G–I) Similar to (D–F), but a typical glia-like cell bearing bushy mVenus-positive processes in a magnified view (filled arrow).
We also detected D1R-negative (Figures 5A–D, empty
arrows) as well as D1R-positive (Figures 5E–H, filled arrows)
neurons in the striatum in the same preparation (Figure 6C; see
also Supplementary Figures 5). Similar results were obtained in
duplicated experiments, implying divergent expressions of D1R
in GFAP-positive astrocytes in the striatum, possibly in a manner
similar to that in neurons in this nucleus in our experimental
condition (Figure 6C). This tendency was supported by a cluster
analysis as well (Ward’s method, data not shown), althoughmuch
larger sampling is required for confirming this tendency.
DISCUSSION
For understanding the role of dopamine in the brain, precise
information on the localization of the five dopamine receptor
subtypes would be of primary importance (Beaulieu and
Gainetdinov, 2011). The expression of D1R has long been
studied, as is also the case with that of D2R (Levey et al., 1993;
Smiley et al., 1994; Yung et al., 1995; Caille et al., 1996; Kliem
et al., 2010; Shao et al., 2013). It is now well established that SNr
and striatum are among major brain nuclei in which D1R is most
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FIGURE 3 | Double immunolabeling of SNr cells dissociated from the adult wild-type mouse brain with anti-D1R and anti-GFAP antibodies. (A–D) A
typical D1R-positive/GFAP-positive SNr astrocyte (filled arrow). A typical D1R-negative (GFAP-negative) SNr neuron is shown in the same field of view (empty arrow).
(A), (B), (C), and (D) represent represent D1R immunofluorescence, GFAP immunofluorescence, differential interference contrast image, and a merged image of
these, respectively. Nuclear staining with DAPI (blue) was overlaid. Inset in (D) depicts a magnified view of D1R-positive synaptic bouton-like structures on the SNr
neuron. D1R-negative small cells bearing no fine process were excluded from the analysis due to too much digestion and/or mechanical damage.
FIGURE 4 | Double immunolabeling of visual cortical cells dissociated from the adult wild-type mouse brain with anti-D1R and anti-GFAP antibodies.
(A-D) Similar to Figure 3, but for cells dissociated from the visual cortex. A typical D1R-negative/GFAP-positive visual cortical astrocyte (filled arrow). A typical
D1R-negative (GFAP-negative) visual cortical neuron is shown in the same field of view (empty arrow). Nuclear staining with DAPI (blue) was overlaid in (A,B,D).
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FIGURE 5 | Double immunolabeling of striatal cells dissociated from the adult wild-type mouse brain with anti-D1R and anti-GFAP antibodies. (A–D)
Similar to Figure 4, but for cells dissociated from the striatum. A typical D1R-positive/GFAP-positive striatal astrocyte (filled arrowhead) is shown. A typical
D1R-negative (GFAP-negative) striatal neuron is also shown in the same field of view (empty arrow). In contrast to (A–D), (E–H) show a typical
D1R-negative/GFAP-positive striatal astrocyte (empty arrowhead). A typical D1R-positive (GFAP-negative) striatal neuron is also shown in the same field of view (filled
arrow). Nuclear staining with DAPI (blue) was overlaid except for (C,G).
FIGURE 6 | Divergence in D1R immunoreactivity of cells acutely dissociated from SNr, visual cortex, and striatum of the adult wild-type mouse brain.
(A–D) The intensity profiles of D1R immunofluorescence, which were measured for isolated cells from SNr (A), visual cortex (B), and striatum (C), were summarized
against the longitudinal diameter of the cell body. Red triangles and black circles represent astrocytes and neurons, respectively. (D) Fluorescence intensity of cells
acutely dissociated from SNr, visual cortex, and striatum, to which only Alexa Fluor 488 donkey anti-goat IgG and Cy3-conjugated donkey anti-rabbit IgG were
applied, without using primary antibodies such as goat polyclonal anti-mouse D1R antibody and polyclonal rabbit anti-GFAP antibody.
abundantly expressed (Levey et al., 1993; Yung et al., 1995; Caille
et al., 1996; Kliem et al., 2010; for reviews see Fallon and Loughlin,
1995; Rommelfanger and Wichmann, 2010). SNc dopaminergic
neurons transmit dopamine on the one hand through their axons
to the striatum, and on the other hand through their dendrites to
the SNr (Geffen et al., 1976; Korf et al., 1976; Nieoullon et al.,
1977; Reubi et al., 1977; Cheramy et al., 1981). However, in the
SNr, possibly due to the non-axonic nature of the dopamine
transmission, the cellular entity receiving the dopamine has yet
to be completely identified.
We demonstrate in the present study that GFAP-
immunopositive astrocytes, which were acutely dissociated
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from the SNr of the adult wild-type mouse, bore fine processes
showing prominent D1R immunoreactivity. Judging from the
staining patterns of the wild-type mouse brains (Supplementary
Figure 1B) as well as the inability of staining D1R-KO brains, the
anti-D1R antibody used appeared highly reliable, leading us to
propose that D1R is expressed in fine processes of GFAP-positive
astrocytes in the SNr of the adult mouse brain. This concept was
further supported by the results using D1R promotor-controlled
mVenus expressing mice.
Region-specific astrocyte heterogeneity has been a subject of
intensive studies (Oberheim et al., 2012). Our results suggest
heterogeneity of D1R immunoreactivity among the GFAP-
positive astrocytes obtained from three areas of the adult
mouse brain (Figure 6). Although some sampling bias cannot
be excluded, it would be difficult to explain such heterogeneity
in D1R immunoreactivity of GFAP-positive astrocytes solely
by reactive responses that might be caused by the dissociation
procedure, since the quantification was made among astrocytes
according to the same experimental condition (see Materials and
Methods). Indeed, the coronal section of Drd1-mVenus mouse
brain showed extensive heterogeneity in the D1R promotor-
controlled fluorescence signal (Figure 2C). Consistently, most
SNr astrocytes were more or less immunopositive for D1R
(Figure 6A), whereas the cortical astrocytes tested (Figure 6B)
showed only little D1R immunoreactivity.
The small diameter (12.9± 2.4µm, Figure 6B) of the neurons
dissociated from the visual cortex suggests difficulty in isolating
large pyramidal neurons from adult mouse brain. The neurons
dissociated might correspond to cells such as pyramidal neurons
reported in the middle layer of the mouse visual cortex (Gilman
et al., 2016). Previous studies in monkey prefrontal cortex
have reported D1R immunoreactivity on pyramidal neurons
(Smiley et al., 1994). Although species difference between primate
and rodent cannot be excluded from responsibility for the
discrepancy (Levey et al., 1993; Smiley et al., 1994), the specificity
and sensitivity of the anti-D1R antibodies tested are of particular
importance for interpretation of the immunoreactivity (Bergson
et al., 1995; Puighermanal et al., 2016).
Further study is needed for elucidating functional roles of the
divergent D1R expression in astrocytes in correlation with the
well-known heterogeneity of neurons in individual brain areas
(Levey et al., 1993; Fallon and Loughlin, 1995). It may be of
interest that the striatal astrocytes tended to show either strong or
minimum D1R immunoreactivity, considering that the principal
neurons (medium spiny neurons) in the striatum are either
positive or negative for D1R (Yung et al., 1995). Investigation for
potential contributions of other glial cells, such as microglia, in
the D1R expression in the SNr, should also be considered (Färber
et al., 2005; Pannell et al., 2014).
So far, evidence for D1R expression in mature astrocytes
has been largely lacking, although astrocytes expressing other
dopamine receptors have been reported by several groups. Kliem
et al. reported occasional expression of dopamine D5 receptor
(D5R) in some glial processes in monkey SNr and internal
globus pallidus by immunoelectronmicroscopy (Kliem et al.,
2010). In prefrontal cortex, D2R expression in astrocytes has been
reported as well (Khan et al., 2001; Negyessy andGoldman-Rakic,
2005; Duffy et al., 2011). Using mice lacking D2R preferentially
in GFAP-expressing cells, Shao et al. reported D2R expression
in astrocytes and its role in suppressing 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity (Shao
et al., 2013). Bosson et al. reported recently that disruption
of dopaminergic transmission can remodel astrocytic calcium
activity within the SNr (Bosson et al., 2015).
It is well established that the major function of SNr is to
regulate motor activity by inhibiting remote nuclei, superior
colliculus, thalamus, and pedunculopontine nucleus of the brain
stem according to inputs from the striatum (Hikosaka et al.,
2000, 2014; Takakusaki et al., 2004). In addition, some groups
including ours have suggested that SNr contributes to sensing
hypoxic/hypoglycemic conditions (Yamada et al., 2001; Yuan
et al., 2004; Yamada and Inagaki, 2005; Velisek et al., 2008; Lutas
et al., 2014). Since fine astrocyte processes contain very small
mitochondria (Derouiche et al., 2015), dopamine might well alter
metabolic activity of astrocytes at the fine processes (Requardt
et al., 2010).
Brain circuits have been largely discussed based on neuron
to neuron connections that convey signals mediated by such
as axo-dendritic and axo-axonic transmissions. Recently, we
reported that astrocytes obtained from the immature mouse
cortex can release glycine in response to dopamine through
reverse operation of glycine transporter 1, in which D1-like
receptors might be involved (Shibasaki et al., 2017). Thus, it
may be of interest to explore whether astrocytes are associated
with the dopamine function in the SNr. Reubi and Sandri,
who examined 38 blocks and 24 freeze-etching replica at the
electronmicroscopic level, reported that nigral dendrites are
consistently separated by one or two thin glial sheaths (Reubi
and Sandri, 1979). Since strongD1R immunoreactivity was found
in fine processes of the SNr astrocyte, the astrocyte might well
be a major candidate to receive dopamine released dendritically.
Further study is required to confirm the present data at the
electronmicroscopic level and to elucidate the functional role of
divergent dopamine receptor immunoreactivity in astrocytes.
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